You are here

A piece of news

The new Consortium BioPol has been established today in l'Hospitalet de Llobregat

AddToAny buttons: 
20.11.2008

BioPol goals are to promote the scientific area, knowledge transfer and the biomedical research in Catalonia. BioPol has been established today in l'Hospitalet de Llobregat and will serve as basis for the creation of new companies and to attract other companies of the pharmaceutical and biotechnological sector of out of Catalonia.
The president of the Generalitat of Catalonia, José Montilla, and the Spanish Minister of Science and Innovation, Cristina Garmendia, have presided the act at the Hospital de Bellvitge. There were also present the Mayor of l'Hospitalet de Llobregat, Núria Marín, the acting president of the University of Barcelona, Josep Samitier, the commissioner for Universities and Research, Palmate Minim, and the president of the Executive Commission of Biocat, Manel Balcells, accompanied by the Catalan Minister of Health, Marina Geli.
BioPol has been promoted by the Generalitat de Catalunya, the City Council of l'Hospitalet de Llobregat, the University of Barcelona and Biocat (BioRegion of Catalonia.)
BioPol’s mission will consist in fostering knowledge-generating activities. Also it will create wealth through the collaboration with already consolidated companies and it will also promote the creation of new companies. These actions will be to the advantage of the health and well-being of citizens.
BioPol project intends to constitute a cluster of sanitary institutions, research centres and sciences of life sector companies formed by the l’Institut d’Investigació Biomèdica de Bellvitge (IDIBELL,) the Institut de Bioenginyeria de Catalunya (IBEC,) the Hospital de Bellvitge, the Institut Català d’Oncologia (ICO,) the Universitat de Barcelona campus (UB) and the future Parc Científic de la Salut BioPol.
In this sense, the activity of the future Frugal CientíficParc will focus on the basic and clinical research in areas of the biomedicine, the bioengineering and biotechnology. It will mean new mixed units of collaboration between both the public and the private one.
BioPol is pioneer with the Barcino, which is based on a robot that produces prosthesis of biocompatible materials for cold thermal projection destined for the biomedical market. Also for the hypobaric chamber, which has already proved the efficiency of intermittent exposure at mock altitude for stimulating the answers of acclimatization of the humans to altitude.

Related content: